Upgrade your dog's health with Pure Pet Food and save 40% off your first order
Pure Pet Food's range of nutritious dog food is made with natural ingredients and no nasties or filler products, and right now you can save 40% off your first order.
Save 40% off the first box + 15% off the next two boxes
BUY HERE
Dog owners are more conscious than ever about what food to feed their pets, indicated by a rise in online searches around choosing hypoallergenic pet food and options for sensitive stomachs.
That's where Pure Pet Food takes the stress out of those decisions with its monthly dog food subscription, delivered to your doorstep.
Recipes are packed with superfoods and essential nutrients designed to help your pup live a longer, healthier, and happier life.
You can get 40% off your first box and 15% off your next two when you sign up through this link before 11:59 pm on 30 September.
Once you sign up for a subscription, it's commitment-free, and you can cancel at any time.
Pure Pet Food creates tailored dog food plans designed by pet nutrition experts to support everything from sensitive stomachs to kidney health.
Meals use real food and range from dishes like turkey with broccoli and spinach, to salmon with sweet strawberries and courgette.
These nutritious Pure Pet Food meals are dehydrated to lock in all the nutrients while making it easy for sensitive tummies to digest.
All you need to do is add a splash of water and stir it.
It's essentially restaurant-level dining for your dog, tailored to their age, weight, and any special dietary needs they may have.
Pet owners have been praising the meal service online, with one happy pet owner sharing, "My dog usually has a super sensitive stomach, but since switching to Pure, it has gotten so much better!"
Another revealed: "We have a fussy, almost 2-year-old GSD.
"Researched a ton about the right food for him, found Pure and thought, let's give it a try!
"He bloody loves it — breakfast and dinner are now his favourite parts of the day."
Another said: "You have given our 12-year-old American Bulldog a whole new lease of life.
"Her energy levels have risen, and you can tell she is feeling better in herself.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
4 minutes ago
- The Sun
Man, 45, died ‘taking de-worming drug for animals after seeing fake claims online it could cure cancer'
A MAN died after taking a de-worming drug for animals as he believed it would cure cancer, an inquest heard. Lee Redpath, 45, was rushed to hospital with signs of liver failure after dosing himself with an anti-parasitic drug called fenbendazole across a three-week period. 7 7 7 He tragically died in Addenbrooke's Hospital, in Cambridge, on April 29. Lee had ordered the drug, believing it to be safe, from a supplier in Ukraine. The 45-year-old saw fake social media posts which claimed fenbendazole could be a cancer cure - despite it being banned for human use. It's designed to be used against a number of gastrointestinal parasites in animals including giardia, roundworms, hookworms, whipworms, tapeworms and pinworms. However, even A-list celebrities have promoted the drug for humans, including actor Mel Gibson. He told Joe Rogan earlier this year how three of his friends were cured of stage four cancer after taking it with the anti-parasitic Ivermectin. The inquest, held in Lawrence Court, Huntingdon, Cambs, heard how Lee believed the de-wormer could prevent cancer. His long-term partner Lauren Laul gave evidence at the inquest. She told how her boyfriend believed it was safe to use and popular in the States. 'He saw it online, thought it was safe, people in America are using it," said Lauren. 'He didn't have medical assistance taking it so I think some sort of warning should be made. 'I am seeing it advertised online and people can get it themselves like Lee did and unknowingly be killing themselves because they didn't have all the information.' Lauren also suggested Lee may have been taking them for as long as two years before his death. Dr Gwilym Webb, a consultant hepatologist at Addenbrooke's warned fenbendazole had 'no proven benefit for preventing or treating cancer in humans.' 7 7 7 He told the inquest Lee was not eligible for a liver transplant due to alcohol misuse in the three months before. But a post-mortem concluded Lee's liver failure was due to the fenbendazole. Assistant coroner for Cambridgeshire and Peterborough, Caroline Jones, concluded Lee died of liver and renal failure due to fenbendazole induced liver injury on a background of alcohol related cirrhosis. 'I was satisfied as to the toxic effects of fenbendazole and that it was this that was the primary cause of the injury," she told the inquest. 'It is a potent anti-worming treatment which was taken at far higher relative doses than had ever been envisaged and over a far longer time scale. 'During his admission he advised doctors that he had been taking the drug fenbendazole, which he purchased online from a supplier in the Ukraine after seeing videos about its supposed anti-cancer properties. 'It was thought likely fenbendazole was the primary cause of the acute injury. Lee's conditions deteriorated despite treatment but he was not a candidate for transplant. 'He improved briefly but on April 27 his condition worsened, it was recognised Lee's organs were failing and he passed away at 6.06 pm on April 29. 'While Lee may have taken fenbendazole with good intentions to improve his health, it constituted a deliberate act with the unintended consequence of his death.' Lauren urged the coroner to write a prevention of future deaths report, but Miss Jones denied her request. The coroner said there was not "sufficient evidence", although she was "concerned" about people buying the drug online. Lee's death was recorded as misadventure. 7
The Guardian
6 minutes ago
- The Guardian
Chemical pollution a threat comparable to climate change, scientists warn
Chemical pollution is 'a threat to the thriving of humans and nature of a similar order as climate change' but decades behind global heating in terms of public awareness and action, a report has warned. The industrial economy has created more than 100 million 'novel entities', or chemicals not found in nature, with somewhere between 40,000 and 350,000 in commercial use and production, the report says. But the environmental and human health effects of this widespread contamination of the biosphere are not widely appreciated, in spite of a growing body of evidence linking chemical toxicity with effects ranging from ADHD to infertility to cancer. 'I suppose that's the biggest surprise for some people,' Harry Macpherson, senior climate associate at Deep Science Ventures (DSV), which carried out the research, told the Guardian. 'Maybe people think that when you walk down the street breathing the air; you drink your water, you eat your food; you use your personal care products, your shampoo, cleaning products for your house, the furniture in your house; a lot of people assume that there's really great knowledge and huge due diligence on the chemical safety of these things. But it really isn't the case.' Over eight months, as part of a project funded by the Grantham Foundation, Macpherson and colleagues spoke to dozens of researchers, non-profit leaders, entrepreneurs and investors, and analysed hundreds of scientific papers. According to the DSV report, more than 3,600 synthetic chemicals from food contact materials – the materials that are used in food preparation and packaging – alone are found in human bodies, 80 of which are of significant concern. Pfas 'forever chemicals', for example, have been found in nearly all humans tested, and are now so ubiquitous that in many locations even rainwater contains levels regarded as unsafe to drink. Meanwhile, more than 90% of the global population breathes air that breaches World Health Organization (WHO) pollution guidelines. When these chemicals contaminate our bodies, the results can be disastrous. The report found there were correlational or causal data linking widely used chemicals with threats to human reproductive, immune, neurological, cardiovascular, respiratory, liver, kidney and metabolic systems. 'One of the main things that came out quite strongly was links between pesticide exposure and reproductive issues,' said Macpherson. 'We saw quite strong links – correlation and causation – for miscarriage and people basically struggling to conceive.' The DSV research adds to previous findings by the Potsdam Institute for Climate Impact Research that we have already far exceeded the safe planetary boundary for environmental pollutants, including plastics. On Sunday, another report warned that the world faces a 'plastics crisis', which is causing disease and death from infancy to old age amid a huge acceleration of plastic production. The report also highlights critical shortcomings in current toxicity assessment, research and testing methods, exposing the ways in which existing checks and balances are failing to protect human and planetary health. 'The way that we've generally done the testing has meant that we've missed a lot of effects,' Macpherson said. He singled out the assessment of endocrine-disrupting chemicals, which are substances that interfere with hormones, causing problems ranging from infertility to cancer. These have been found to confound the traditional assumption that lower doses will invariably have lesser effects. 'One of the things is that when you have a chemical which is interfering with the endocrine system, it sometimes has a nonlinear response. So you'll see that there'll be a response at a very low dose, which you wouldn't be able to predict from its behaviour at a high dose.' DSV describes itself as a 'venture creator' that spins out companies aimed at tackling big problems in environmental and human health issues. Part of the purpose of the report is to identify problem areas that can be tackled by innovation. Sign up to Down to Earth The planet's most important stories. Get all the week's environment news - the good, the bad and the essential after newsletter promotion Currently, chemical toxicity as an environmental issue receives just a fraction of the funding that is devoted to climate change, a disproportionality that Macpherson says should change. 'We obviously don't want less funding going into the climate and the atmosphere,' he said. 'But this we think – really, proportionally – needs more attention.' However, there were features of the problem that mean it lends itself more easily to solutions. 'The good thing is that this can be potentially quite easily consumer-driven if people start to worry about things they're personally buying,' Macpherson said. 'There isn't necessarily the need for a massive collective action; it can just be demand for safer products, because people want safer products.' For his part, since starting the research, Macpherson is careful about what touches his food. He cooks with a cast-iron skillet. He especially avoids heating food in plastic. 'Unfortunately, it is a recommendation to eat more organic food, but it is more expensive in general. So at least washing fruit and vegetables before eating them, but organic if you can afford it.'
The Independent
33 minutes ago
- The Independent
Patients whose lives were ruined after being ‘needlessly given cancer drug for years' sue NHS trust
More than 20 patients who say their quality of life was wrecked when they were needlessly given a highly toxic cancer drug are suing the NHS trust involved. Some people were prescribed temozolomide – which should normally be used for only six months – for more than a decade during treatment by the University Hospitals Coventry and Warwickshire NHS Trust. They say the overprescribing left them with side-effects including secondary cancers and crippling fatigue. Earlier this year the Care Quality Commission was looking into at least 14 cases, but lawyers say more are emerging all the time. An investigation by lawyers Brabners found that, over the past two decades, numerous patients with brain and spinal tumours under the care of Professor Ian Brown were routinely exposed to prolonged and in some cases 'unnecessary' use of the chemotherapy drug, which has severe side-effects including extreme fatigue, confusion, sickness and seizures. The time periods temozolomide was given for allegedly ran contrary to medical and scientific guidelines. Standard NHS procedure is to use the drug over six months, and the drug manufacturer advises it be used for up to 12 months. One man said he was prescribed it for nearly two years longer than necessary, suffering extreme fatigue and low mood as a result. A woman in her twenties said she was misdiagnosed with cancer, receiving the drug needlessly for about eight years. Some patients are now having treatment for secondary cancers allegedly linked to overuse of temozolomide, the lawyers claim. Others claimed its prolonged use left them unable to pursue career ambitions and normal day-to-day activities because the chemotherapy was debilitating, with a long recovery time. Some reported loss of fertility or abnormal blood test results. The legal team says data shows that the trust's spending on the drug of £3.6m from 2009 to 2024 is 10 times that of other NHS oncology departments. The lawyers are now calling for an extended patient safety review and independent investigation, focusing in particular on treatment received by patients under Prof Brown dating back to 2006. The trust has been conducting an internal patient safety review, covering 2017 to 2023, when Prof Brown retired. A patient who identified only as Michael received an extra 22 cycles of temozolomide at the trust, despite his scans being stable. Prof Brown was not present during consultations, and Michael said he was always seen by a clinical nurse specialist. After suffering extreme fatigue and low mood, he learnt through news reports of mistreatment –not from the trust – that he should not have remained on treatment for so long, according to his lawyers. Another patient, identified only as Becky, says she received at least 100 cycles of the drug unnecessarily after being misdiagnosed with a brain tumour. Fiona Tinsley, head of medical negligence at Brabners, said: 'The extent of this scandal, and the physical and mental impact it has had on Prof Brown's patients cannot be underestimated.' She added: 'We believe there are many more patients out there who haven't yet come forward and some who may have sadly passed away. 'While we welcome the ongoing investigations being undertaken by the General Medical Council and Royal College of Physicians, we believe a full independent inquiry is necessary – including an extension of the trust's own review back to 2006 – not only to ensure justice for victims, but that processes are put in place to better identify and prevent such failings happening again.' A spokesperson for the trust told The Independent: 'We have comprehensively reviewed and spoken to all individuals who were receiving temozolomide (TMZ) treatment at the end of 2023 to ensure appropriate support and care plans are in place. 'A glioblastoma is an aggressive brain tumour with fewer than two per cent of patients surviving longer than 10 years. This is an extremely complex condition and all modes of treatment – surgery, chemotherapy and radiotherapy – carry the risk of complications and side-effects. 'National Institute for Health and Care Excellence (Nice) guidelines recognise that clinicians can exercise professional judgment appropriate to individual circumstances when offering treatment to patients. 'We have commissioned the Royal College of Physicians to conduct an independent review of a representative cohort of patients who received greater than 12 cycles of adjuvant TMZ between 2017 and 2023. 'As this process is ongoing, it would be inappropriate to comment further at this stage." It's understood that CQC inspectors have been in touch with the trust to understand the details, and seek assurances that patients are not at risk. The regulator will be reviewing more information to judge whether it needs to be involved.
